IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pharma/fine chemicals roundup—1 July 2014

7:32 AM MDT | July 1, 2014 | Deepti Ramesh

Feature FDA tightens control over India’s API manufacturers FDA has, since 2013, issued warning letters to several active pharmaceutical ingredient (API) manufacturing facilities in India. According to figures from the FDA Web site, warning letters were issued in 2011 to three API manufacturing facilities in India, but no such warnings were issued in 2012. Experts say the recent rise in letters to India is linked to a stronger FDA presence there and inspections at short notice. “The FDA has now set up a strong base in India with a group of inspectors...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa